This means the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed. The Obesity Action Coalition (OAC), The Obesity Society (TOS), and The Obesity Medicine Association (OMA) have released a statement expressing their concerns for patients using the compounded GLP-1 alternatives
2025 exposed a lot of problems in the online tirzepatide space
Common side effects with dose escalation include nausea, vomiting, constipation, and reduced appetite, typically occurring most intensely for 1-2 weeks after each dose increase before tolerating improves
Studies indicate that these medications affect areas of the brain involved in both appetite regulation and sexual behavior [6]
Regular follow-ups, monitoring of hormone levels, and adjustments to treatment, when necessary, provide our patients with a sense of accountability, support, and guidance